AMRI Announces Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Albany Molecular Research (AMRI) Tops Q3 EPS by 1c
November 5, 2015 7:19 AM ESTAlbany Molecular Research (NASDAQ: AMRI) reported Q3 EPS of $0.14, $0.01 better than the analyst estimate of $0.13. Revenue for the quarter came in at $101.4 million versus the consensus estimate of $95.15 million.
Albany Molecular Research reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
... More